Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.4196
+0.0006 (0.14%)
At close: May 12, 2025, 4:00 PM
0.3500
-0.0696 (-16.59%)
After-hours: May 12, 2025, 7:39 PM EDT
Entero Therapeutics Market Cap
Entero Therapeutics has a market cap or net worth of $2.00 million as of May 12, 2025. Its market cap has decreased by -0.02% in one year.
Market Cap
2.00M
Enterprise Value
1.98M
1-Year Change
-0.02%
Ranking
Category
Stock Price
0.42
Market Cap Chart
Since October 11, 2016, Entero Therapeutics's market cap has decreased from $49.20M to $2.00M, a decrease of -95.94%. That is a compound annual growth rate of -31.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.00M | -33.33% |
| Dec 31, 2024 | 3.00M | 7.14% |
| Dec 29, 2023 | 2.80M | -45.10% |
| Dec 30, 2022 | 5.10M | -71.67% |
| Dec 31, 2021 | 18.00M | -38.98% |
| Dec 31, 2020 | 29.50M | 8.46% |
| Dec 31, 2019 | 27.20M | 32.68% |
| Dec 31, 2018 | 20.50M | -51.19% |
| Dec 29, 2017 | 42.00M | -7.89% |
| Dec 30, 2016 | 45.60M | -7.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |